Our vision
A world where prenatal ultrasound is safer, better supported, and universally accessible.
Make Obstretric screening accurate, safe, and less user-dependant
Every expectant parent deserves the reassurance of a precise and reliable obstetric screening, yet access to high-quality ultrasound diagnostics remains inconsistent worldwide. Variability in expertise, time constraints, and human error can lead to missed pathologies, delayed interventions, and unnecessary stress for families.
By making obstetric screening more accurate, safer, and less user-dependent, we envision a future where every pregnancy is monitored with the same level of precision regardless of location or the clinician’s experience. Standardized, high-quality diagnostics mean earlier detection of complications, improved maternal and fetal outcomes, and a reduction in preventable adverse events.
By making obstetric screening more accurate, safer, and less user-dependent, we envision a future where every pregnancy is monitored with the same level of precision regardless of location or the clinician’s experience. Standardized, high-quality diagnostics mean earlier detection of complications, improved maternal and fetal outcomes, and a reduction in preventable adverse events.
Words from Our CEO
”At Diagnoly, we believe no parent or healthcare provider should experience uncertainty when it comes to mother-fetal care. Our aim is to bring greater security and peace of mind to mothers and caregivers, improve clinical outcomes, and be a trusted partner for all healthcare professionals.
We choose a longer and much more challenging road: to make a true real-time technology analyzing the live ultrasound scan. We believed that it was worth the effort, as this technology provides a secure way to analyze such complex fetal organs as heart and brain in the most complete way.”
We choose a longer and much more challenging road: to make a true real-time technology analyzing the live ultrasound scan. We believed that it was worth the effort, as this technology provides a secure way to analyze such complex fetal organs as heart and brain in the most complete way.”
Ivan Voznyuk
Chief Executive Officer & Co-Founder

Our Journey
2021
The work has started with an
access to first datasets
2022
Pre-seed funding secured, supported by the i-Lab grant
2024
FDA 510(k) clearance for fetal heart anatomy
2025
CE marking for fetal heart anatomy
2025
€5.5M seed funding round
Smarter Ultrasound for Better Outcomes
Discover how real-time AI can help you detect more and miss less without changing the way you scan